Masimo EBITDA Margin 2010-2025 | MASI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Masimo (MASI) over the last 10 years. The current EBITDA margin for Masimo as of March 31, 2025 is .
Masimo EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $2.13B $-0.14B -6.49%
2024-12-31 $2.10B $-0.16B -7.68%
2024-09-30 $1.89B $0.25B 13.39%
2024-06-30 $1.86B $0.25B 13.30%
2024-03-31 $1.82B $0.24B 12.95%
2023-12-31 $2.05B $0.24B 11.57%
2023-09-30 $2.12B $0.32B 15.26%
2023-06-30 $2.19B $0.31B 13.95%
2023-03-31 $2.30B $0.34B 14.94%
2022-12-31 $2.04B $0.35B 17.05%
2022-09-30 $1.75B $0.28B 16.09%
2022-06-30 $1.50B $0.33B 21.68%
2022-03-31 $1.24B $0.31B 24.68%
2021-12-31 $1.24B $0.31B 25.18%
2021-09-30 $1.21B $0.30B 24.71%
2021-06-30 $1.18B $0.29B 24.47%
2021-03-31 $1.17B $0.28B 24.13%
2020-12-31 $1.14B $0.28B 24.83%
2020-09-30 $1.10B $0.28B 25.34%
2020-06-30 $1.05B $0.27B 25.67%
2020-03-31 $0.98B $0.26B 26.41%
2019-12-31 $0.94B $0.24B 25.99%
2019-09-30 $0.91B $0.24B 25.82%
2019-06-30 $0.90B $0.23B 25.89%
2019-03-31 $0.88B $0.23B 26.31%
2018-12-31 $0.86B $0.23B 26.66%
2018-09-30 $0.84B $0.22B 26.07%
2018-06-30 $0.83B $0.21B 25.91%
2018-03-31 $0.81B $0.21B 25.56%
2017-12-31 $0.79B $0.20B 25.82%
2017-09-30 $0.78B $0.48B 61.81%
2017-06-30 $0.76B $0.48B 62.93%
2017-03-31 $0.74B $0.47B 63.46%
2016-12-31 $0.71B $0.45B 63.53%
2016-09-30 $0.68B $0.16B 24.15%
2016-06-30 $0.66B $0.16B 23.34%
2016-03-31 $0.65B $0.15B 22.57%
2015-12-31 $0.63B $0.14B 21.55%
2015-09-30 $0.63B $0.13B 20.93%
2015-06-30 $0.62B $0.13B 20.26%
2015-03-31 $0.60B $0.11B 18.94%
2014-12-31 $0.59B $0.12B 19.76%
2014-09-30 $0.57B $0.10B 16.93%
2014-06-30 $0.55B $0.09B 16.97%
2014-03-31 $0.55B $0.10B 18.00%
2013-12-31 $0.55B $0.09B 16.85%
2013-09-30 $0.54B $0.10B 18.84%
2013-06-30 $0.52B $0.10B 18.51%
2013-03-31 $0.51B $0.10B 18.82%
2012-12-31 $0.49B $0.09B 19.07%
2012-09-30 $0.47B $0.09B 19.24%
2012-06-30 $0.46B $0.09B 20.09%
2012-03-31 $0.45B $0.09B 20.45%
2011-12-31 $0.44B $0.09B 21.41%
2011-09-30 $0.43B $0.10B 21.94%
2011-06-30 $0.43B $0.10B 22.79%
2011-03-31 $0.42B $0.10B 23.10%
2010-12-31 $0.41B $0.11B 27.59%
2010-09-30 $0.39B $0.11B 28.50%
2010-06-30 $0.38B $0.11B 29.02%
2010-03-31 $0.36B $0.11B 30.03%
2009-12-31 $0.35B $0.09B 25.50%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.324B $2.094B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $199.668B 87.45
Thermo Fisher Scientific (TMO) United States $151.715B 18.35
Edwards Lifesciences (EW) United States $45.473B 29.82
Alcon (ALC) Switzerland $43.302B 29.26
IDEXX Laboratories (IDXX) United States $42.214B 48.51
DexCom (DXCM) United States $33.984B 52.53
IQVIA Holdings (IQV) United States $26.351B 14.76
Mettler-Toledo (MTD) United States $24.614B 29.27
STERIS (STE) Ireland $23.975B 26.41
Waters (WAT) United States $20.898B 29.49
SONOVA HOLDING (SONVY) Switzerland $18.583B 0.00
Hologic (HOLX) United States $14.336B 15.58
Sysmex ADR (SSMXY) Japan $10.191B 28.91
Penumbra (PEN) United States $10.026B 78.69
Globus Medical (GMED) United States $8.112B 19.33
Teleflex (TFX) United States $5.426B 8.96
Glaukos (GKOS) United States $5.314B 0.00
TransMedics (TMDX) United States $4.703B 102.24
Integer Holdings (ITGR) United States $4.233B 22.18
PROCEPT BioRobotics (PRCT) United States $3.481B 0.00
LivaNova (LIVN) United Kingdom $2.505B 14.92
Veracyte (VCYT) United States $2.151B 30.18
Nihon Kohden (NHNKY) Japan $2.052B 23.53
Elekta AB (EKTAY) Sweden $1.975B 17.76
Alphatec Holdings (ATEC) United States $1.861B 0.00
Tandem Diabetes Care (TNDM) United States $1.384B 0.00
Artivion (AORT) United States $1.236B 115.80
Pulse Biosciences (PLSE) United States $1.150B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $1.054B 5.60
Beta Bionics (BBNX) United States $0.827B 0.00
SiBone (SIBN) United States $0.805B 0.00
IRadimed (IRMD) United States $0.769B 39.03
RxSight (RXST) United States $0.611B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.576B 8.96
Delcath Systems (DCTH) United States $0.570B 0.00
Mesa Laboratories (MLAB) United States $0.567B 13.30
OrthoPediatrics (KIDS) United States $0.515B 0.00
AxoGen (AXGN) United States $0.497B 0.00
AngioDynamics (ANGO) United States $0.449B 0.00
NeuroPace (NPCE) United States $0.431B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.430B 0.00
ClearPoint Neuro (CLPT) United States $0.390B 0.00
Semler Scientific (SMLR) United States $0.368B 9.79
Treace Medical Concepts (TMCI) United States $0.365B 0.00
Pacific Biosciences Of California (PACB) United States $0.342B 0.00
908 Devices (MASS) United States $0.249B 0.00
Neuronetics (STIM) United States $0.245B 0.00
Tactile Systems Technology (TCMD) United States $0.233B 14.14
Sight Sciences (SGHT) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.213B 0.00
Biosig Technologies (BSGM) United States $0.200B 0.00
Inogen (INGN) United States $0.177B 0.00
Spectral Diagnostics (EDTXF) Canada $0.173B 0.00
CVRx (CVRX) United States $0.171B 0.00
Anteris Technologies Global (AVR) Australia $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.161B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Lucid Diagnostics (LUCD) United States $0.140B 0.00
Accuray (ARAY) United States $0.133B 0.00
Atossa Genetics (ATOS) United States $0.116B 0.00
Microbot Medical (MBOT) United States $0.102B 0.00
Monogram Orthopaedics (MGRM) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.081B 49.20
InspireMD (NSPR) United States $0.077B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
Positron (POSC) United States $0.052B 0.00
Spectral AI (MDAI) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.036B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.29
Longview Acquisition II (LGV) United States $0.000B 0.00